Evidence map›Paper›PMID 41251385›Full record

ArticleBritish journal of haematology2025

NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.

Gaurav Agarwal, Mohammad Kazeroun, Mirian Salazar, Khrystal McBean, Ananya Kannan, Jemma Larham, Sherin Varghese, Berrin Balik, Joseph Browning, Alexis Caulier and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Gaurav AgarwalDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-6710-8652
Mohammad KazerounOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Mirian SalazarOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Khrystal McBeanDepartment of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Ananya KannanOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Jemma LarhamDepartment of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Sherin VargheseDepartment of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Berrin BalikOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Joseph BrowningDepartment of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Alexis CaulierDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Y L Tracey ChanUniversity Hospitals Birmingham NHS Trust, Birmingham, UK.ORCID https://orcid.org/0000-0003-1538-8485
Hannah GilesUniversity Hospitals Birmingham NHS Trust, Birmingham, UK.
Matthew JennerDepartment of Haematology, University Hospital Southampton, Southampton, UK.
Bhuvan KishoreUniversity Hospitals Birmingham NHS Trust, Birmingham, UK.
Guy PrattUniversity Hospitals Birmingham NHS Trust, Birmingham, UK.ORCID https://orcid.org/0000-0002-6937-2852
Neil RabinDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-4998-5205
Rebecca RobinsonUniversity Hospitals Birmingham NHS Trust, Birmingham, UK.
Alexis TalbotDepartment of Haematology, Hôpital Saint Louis, APHP, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0001-6734-413X
Zoé van de WyngaertSorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.ORCID https://orcid.org/0000-0001-9463-2823
Ke XuDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-2453-4475
Sally MooreDepartment of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Eileen BoyleDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Naser Ansari-PourOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Karthik RamasamyOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Angela HamblinOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Anjan ThakurtaOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Sarah GoodingOxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.

Funding

Cancer Research UK RCCCSF-Nov21\100004NIHR Oxford Biomedical Research Centre (BRC)Oxford Translational Myeloma Centre
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer geneticsclinical cytogeneticsdiagnostic haematologyfishgenetic analysismyeloma

Identifiers

PMID41251385
PMCPMC12624159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.